Pulmonary Fibrosis Following Therapy with Melphalan for Multiple Myeloma
Overview
Authors
Affiliations
A patient suffering from multiple myeloma developed pulmonary fibrosis, of a type known to be associated wtih busulphan, whilst being treated with Melphalan. The possible role of Melphalan as the causative agent is discussed. Reference is made to other possible aetiological agents and the reasons for their exclusion are discussed.
Pulmonary fibrosis following therapy with melphalan: report of two cases.
Major P, LAURIN S, Bettez P Can Med Assoc J. 1980; 123(3):197-202.
PMID: 7260761 PMC: 1704716.
Oakhill A, Green I, Knowlson G, Cameron A, Shah K, Hill F J Clin Pathol. 1981; 34(5):495-500.
PMID: 6941971 PMC: 493331. DOI: 10.1136/jcp.34.5.495.
Relationship of gold and penicillamine therapy to diffuse interstitial lung disease.
Scott D, Bradby G, Aitman T, Zaphiropoulos G, HAWKINS C Ann Rheum Dis. 1981; 40(2):136-41.
PMID: 6784683 PMC: 1000695. DOI: 10.1136/ard.40.2.136.
Histopathology of the lung after bone marrow transplantation.
Sloane J, Depledge M, Powles R, Morgenstern G, Trickey B, Dady P J Clin Pathol. 1983; 36(5):546-54.
PMID: 6341414 PMC: 498284. DOI: 10.1136/jcp.36.5.546.
Drug-induced pulmonary fibrosis.
Adamson I Environ Health Perspect. 1984; 55:25-36.
PMID: 6203733 PMC: 1568370. DOI: 10.1289/ehp.845525.